Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

National Wilms Tumor Study-5 -- Treatment of Relapsed Patients, A National Wilms Tumor Study Group Phase III Study

NCT00002610 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00002610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
National Wilms Tumor Study-5 -- Treatment of Relapsed Patients, A National Wilms Tumor Study Group Phase III Study
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
January 31, 1996
Completion date
February 28, 2006
Enrollment
203 (actual)
Sites
235

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer